Persistence of chromosomal abnormalities additional to the Philadelphia chromosome after Philadelphia chromosome disappearance during imatinib therapy for chronic myeloid leukemia.

Zaccaria, Alfonso

Persistence of chromosomal abnormalities additional to the Philadelphia chromosome after Philadelphia chromosome disappearance during imatinib therapy for chronic myeloid leukemia. [electronic resource] - Haematologica Apr 2007 - 564-5 p. digital

Publication Type: Letter; Research Support, Non-U.S. Gov't

1592-8721

10.3324/haematol.10783 doi


Adult
Aged
Aged, 80 and over
Aneuploidy
Antineoplastic Agents--therapeutic use
Benzamides
Chromosome Aberrations
Chromosome Deletion
Clone Cells--pathology
Drug Resistance, Neoplasm
Female
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--blood
Male
Monosomy
Neoplastic Cells, Circulating
Philadelphia Chromosome
Piperazines--therapeutic use
Prognosis
Pyrimidines--therapeutic use
Remission Induction
Trisomy